跳至主要内容
临床试验/CTRI/2025/07/090263
CTRI/2025/07/090263尚未招募2 期

A Randomized open labeled controlled clinical trial to assess an efficacy of Amalaki beej churna with Tandulodaka in the management of Asrugdara with special reference to menorrhagia

Manasi Nitin Sonawane1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年7月15日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To determine the efficacy of Amalaki Beej churna with tandulodaka in Asrugdara W.S.R. to menorrhagia

研究概览

简要总结

This is a randomised, open-label, controlled clinical study to evaluate the efficacy of Amalaki beej churna with Tandulodaka orally in Asrugdara, which will be conducted in the OPD of Matoshri Asarabai Darade Ayurveda Mahavidyalaya, Babhulgaon. The primary outcome measures will be to assess the effect of the drug after 7th, 14th and 28th day, and the secondary outcome will be measured after 3 menstrual cycles during treatment and after 1 month after the treatment is completed.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Selection irrespective of marital status, parity, socioeconomic status.
  • Patients having signs and symptoms of Asrugdara.
  • Excessive bleeding more than 2 consecutive cycles.
  • Excessive bleeding (more than 80ml) or more than 7 days per vagina during mensuration.
  • Hb more than 7 gm percentage.

排除标准

  • 未提供

结局指标

主要结局

To determine the efficacy of Amalaki Beej churna with tandulodaka in Asrugdara W.S.R. to menorrhagia

时间窗: 1 week,2 week,4 week,3 months

次要结局

  • To study control on amount and duration of bleeding(To study efficacy in reducing associated symptoms)

研究者

发起方
Manasi Nitin Sonawane
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Manasi Nitin Sonawane

Matoshree Asarabai Darade Ayurveda Mahavidyalaya Babhulgaon Tal-Yeola Dist-Nashik

研究点 (1)

Loading locations...

相似试验